| MolName | 3-[[5-(carboxymethyl)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| MolecularFormula | C33H30N10O10S3 |
| Smiles | OC(Cc1nnc(SCC(CSC2C3NC(C(c(cc4)ccc4O)NC(C4=CNc(nc(N(CC5)CCN5C=O)nc5)c5C4=O)=O)=O)=C(C(O)=O)N2C3=O)s1)=O |
| InChI | InChI=1S/C33H30N10O10S3/c44-14-41-5-7-42(8-6-41)32-35-10-18-25(48)19(11-34-26(18)38-32)27(49)36-22(15-1-3-17(45)4-2-15)28(50)37-23-29(51)43-24(31(52)53)16(12-54-30(23)43)13-55-33-40-39-20(56-33)9-21(46)47/h1-4,10-11,14,22-23,30,45H,5-9,12-13H2,(H,36,49)(H |
| InChIK | FJHZJEUKOARDAO-UHFFFAOYSA-N |
| TotalMolweight | 822.859 |
| Molweight | 822.859 |
| MonoisotopicMass | 822.13085 |
| CLogP | -1.6126 |
| CLogS | -4.039 |
| H Acceptors | 20 |
| H Donors | 6 |
| TotalSurfaceArea | 556.56 |
| Relative PSA | 0.4938 |
| PolarSurfaceArea | 356.39 |
| Druglikeness | 14.193 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | low |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.53571 |
| Fragments | 1 |
| Non HAtoms | 56 |
| NonCHAtoms | 23 |
| Electronegative Atoms | 23 |
| StereoCenters | 3 |
| Rotatable Bond | 12 |
| Rings Closures | 7 |
| Small Rings | 7 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 17 |
| Sp3Atoms | 15 |
| Symmetricatoms | 4 |
| Amides | 4 |
| Aromatic Nitrogens | 4 |
| AcidicOxygens | 2 |
| StereoCon | unknown chirality |
Click to Load Molecule:
1 - 3-[[5-(carboxymethyl)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 2 - 3-[[5-(carboxymethyl)-1,3,4-thiadiazol-2-yl]sulfanylmethyl]-7-[[2-[[2-(4-formylpiperazin-1-yl)-5-oxo-8H-pyrido[2,3-d]pyrimidine-6-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid